4.6 Article

SUBTYPING SOCIAL ANXIETY DISORDER IN DEVELOPED AND DEVELOPING COUNTRIES

期刊

DEPRESSION AND ANXIETY
卷 27, 期 4, 页码 390-403

出版社

WILEY
DOI: 10.1002/da.20639

关键词

social anxiety disorder; social phobia; epidemiology; subtype

资金

  1. Japan Ministry of Health. Labour and Welfare [H14 - TOKUBETSU -026, H16-KOKOR0-013]
  2. Lebanese Ministry of Public Health
  3. WHO (Lebanon)
  4. Fogarty International
  5. Act for Lebanon
  6. Janssen Cilag
  7. Eli Lilly
  8. GlaxoSmithKline
  9. Roche: Novartis
  10. National Institute of Psychiatry Ramon de la Fuente [4280]
  11. National Council on Science and Technology [CONACyT-G30544-H]
  12. New Zealand Ministry of Health
  13. Alcohol Advisory Council
  14. Health Research Council
  15. WHO (Geneva)
  16. WHO (Nigeria)
  17. Federal Ministry of Health, Abuja, Nigeria
  18. Ministry of Public Health (former Ministry of Health)
  19. US National Institute of Mental Health [R01-MH059575]
  20. National Institute of Drug
  21. South African Department of Health
  22. FOGARTY INTERNATIONAL CENTER [R03TW006481] Funding Source: NIH RePORTER
  23. NATIONAL INSTITUTE OF MENTAL HEALTH [R13MH066849, R01MH070884, R01MH061905, R01MH059575, R01MH069864, U01MH060220] Funding Source: NIH RePORTER
  24. NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016558] Funding Source: NIH RePORTER

向作者/读者索取更多资源

SAD and numerous outcomes (age-of-onset, persistence, severity, comorbidity, treatment) were examined. Additional analyses examined associations with number of performance fears Versus number of interactional fears. Results: Lifetime social fears are quite common in both developed (15.9%) and developing (14.3%) countries, but lifetime SAD is much more common in the former (6.1%) than latter (2.1%) countries. Among those with SAD, persistence, severity, comorbidity, and treatment have dose response relationships with number of social fears, with no clear nonlinearity in relationships that would support a distinction between generalized and non-generalized SAD. The distinction between performance fears and interactional fears is generally not important in predicting these same outcomes. Conclusion: No evidence is found to support subtyping SAD on the basis of either number of social fears or number of performance fears versus number of interactional fears. Depression and Anxiety 27:390-403, 2010. (C) 2009 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据